Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3818780rdf:typepubmed:Citationlld:pubmed
pubmed-article:3818780lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:3818780lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:3818780lifeskim:mentionsumls-concept:C0016030lld:lifeskim
pubmed-article:3818780lifeskim:mentionsumls-concept:C0043346lld:lifeskim
pubmed-article:3818780lifeskim:mentionsumls-concept:C0080194lld:lifeskim
pubmed-article:3818780lifeskim:mentionsumls-concept:C0205282lld:lifeskim
pubmed-article:3818780lifeskim:mentionsumls-concept:C0041942lld:lifeskim
pubmed-article:3818780lifeskim:mentionsumls-concept:C0001758lld:lifeskim
pubmed-article:3818780lifeskim:mentionsumls-concept:C0205307lld:lifeskim
pubmed-article:3818780lifeskim:mentionsumls-concept:C0085732lld:lifeskim
pubmed-article:3818780lifeskim:mentionsumls-concept:C0069225lld:lifeskim
pubmed-article:3818780pubmed:issue1lld:pubmed
pubmed-article:3818780pubmed:dateCreated1987-4-22lld:pubmed
pubmed-article:3818780pubmed:abstractTextThe XP cell strain XP29MA, its malignant counterpart XP29MAmal and a normal human fibroblast strain were tested for colony-forming ability after treatment with HECNU in the presence of m6G, m6Gua, and he7G. In XP29MAmal, inhibition of post-HECNU colony-forming ability was 35% when 0.25 mM of either m6G or m6Gua were present, whereas in XP29MA and the normal fibroblast strain no inhibition was detected. The he7G caused a similar but smaller inhibitory effect in XP29MAmal, but failed to do so in XP29MA. HECNU predominantly exerts its killing effect by alkylating O-6 of DNA-bound guanine and causing DNA interstrand crosslinks. Alkylation of O-6 of guanine can be repaired by 6-methylguanine-DNA methyltransferase. From our experiments we conclude that in XP29MAmal this methyltransferase was inhibited in the presence of the 6-alkylguanines, thus leaving more 2-chloroethylated sites in DNA unrepaired. This results in sensitization in terms of decreased colony-forming ability observed only in the malignant cell line.lld:pubmed
pubmed-article:3818780pubmed:languageenglld:pubmed
pubmed-article:3818780pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3818780pubmed:citationSubsetIMlld:pubmed
pubmed-article:3818780pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3818780pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3818780pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3818780pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3818780pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3818780pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3818780pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3818780pubmed:statusMEDLINElld:pubmed
pubmed-article:3818780pubmed:issn0171-5216lld:pubmed
pubmed-article:3818780pubmed:authorpubmed-author:EisenbrandGGlld:pubmed
pubmed-article:3818780pubmed:authorpubmed-author:MüllerNNlld:pubmed
pubmed-article:3818780pubmed:authorpubmed-author:ThielmannH...lld:pubmed
pubmed-article:3818780pubmed:authorpubmed-author:EdlerLLlld:pubmed
pubmed-article:3818780pubmed:issnTypePrintlld:pubmed
pubmed-article:3818780pubmed:volume113lld:pubmed
pubmed-article:3818780pubmed:ownerNLMlld:pubmed
pubmed-article:3818780pubmed:authorsCompleteYlld:pubmed
pubmed-article:3818780pubmed:pagination67-72lld:pubmed
pubmed-article:3818780pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3818780pubmed:meshHeadingpubmed-meshheading:3818780-...lld:pubmed
pubmed-article:3818780pubmed:meshHeadingpubmed-meshheading:3818780-...lld:pubmed
pubmed-article:3818780pubmed:meshHeadingpubmed-meshheading:3818780-...lld:pubmed
pubmed-article:3818780pubmed:meshHeadingpubmed-meshheading:3818780-...lld:pubmed
pubmed-article:3818780pubmed:meshHeadingpubmed-meshheading:3818780-...lld:pubmed
pubmed-article:3818780pubmed:meshHeadingpubmed-meshheading:3818780-...lld:pubmed
pubmed-article:3818780pubmed:meshHeadingpubmed-meshheading:3818780-...lld:pubmed
pubmed-article:3818780pubmed:meshHeadingpubmed-meshheading:3818780-...lld:pubmed
pubmed-article:3818780pubmed:meshHeadingpubmed-meshheading:3818780-...lld:pubmed
pubmed-article:3818780pubmed:meshHeadingpubmed-meshheading:3818780-...lld:pubmed
pubmed-article:3818780pubmed:meshHeadingpubmed-meshheading:3818780-...lld:pubmed
pubmed-article:3818780pubmed:meshHeadingpubmed-meshheading:3818780-...lld:pubmed
pubmed-article:3818780pubmed:year1987lld:pubmed
pubmed-article:3818780pubmed:articleTitle6-Methylguanine and 6-methylguanosine inhibit colony-forming ability in a malignant xeroderma pigmentosum cell line but not in other xeroderma pigmentosum and normal human fibroblast strains after treatment with 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl)-urea.lld:pubmed
pubmed-article:3818780pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3818780pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed